Unexpected Consequences of Insulin Resistance for the Heart
Unexpected Consequences of Insulin Resistance for the Heart
批准号:
9212832
负责人:
Romain Harmancey
金额:
$24.84万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-02-01 至 2019-01-31
关键词:
AddressAttenuatedAwardBiochemicalCalciumCardiacCardiovascular DiseasesCardiovascular systemCellsCessation of lifeChemicalsChronicCoronary ArteriosclerosisDevelopmentDiabetes MellitusEnergy MetabolismEnergy-Generating ResourcesEnsureEventFailureFatty AcidsFatty acid glycerol estersFunctional disorderFutureGene ExpressionGenesGenetic TranscriptionGlucoseGlycolysisGoalsHeartHeart failureHepaticHexosaminesHyperglycemiaImpairmentIn VitroInsulinInsulin ResistanceInvestigationKnowledgeLaboratoriesLinkMechanicsMediatingMediator of activation proteinMentorsMetabolicMetabolismModelingMolecularMolecular BiologyMyocardialMyocardial ContractionNon-Insulin-Dependent Diabetes MellitusOrganismOxidative StressPathway interactionsPentosephosphate PathwayPerceptionPhasePhysiologicalPoisonPoisoningProcessPumpPyruvateResearchRisk FactorsSignal TransductionSkeletal MuscleStressTechniquesTestingThinnessTissuesWorkWorkloadbasebiological adaptation to stressblood glucose regulationdesensitizationdesigndisabilityexperiencefetalfetal reactivityglucose metabolismglucose uptakeheart functionimpaired capacityimprovedinsulin signalingmitochondrial uncoupling protein 3noveloxidationprematurepressurepreventprogramsprotein degradationresponseskillstranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
My immediate goal is to acquire the necessary skills and expertise to make a successful transition to
independence in the academic field of basic cardiovascular research. The long term goals of this work are to
advance our knowledge on the molecular mechanisms that control glucose and fatty acid utilization in the
heart. Premature death and disability from cardiovascular diseases are dire complications in diabetes.
Diabetes is associated with high circulating levels of glucose and fatty acids, which are both energy providing
substrates for the heart. Like other insulin-responsive tissues in the organism, the heart in diabetes becomes
insulin resistant. Because impaired glucose uptake in response to insulin is the main feature of myocardial
insulin resistance (MIR), I propose that MIR is part of an adaptive program with which the heart protects
itself from the hyperglycemic milieu of diabetes mellitus. The rationale arises from the observation that
increased glucose supply to the heart results in rates of glucose uptake greater than rates of glucose oxidation,
the intracellular accumulation of glucose intermediates and, subsequently, contractile dysfunction. Specific
Aim 1 will determine the effects of hyperglycemia on cardiac gene expression. This aim will test the hypothesis
that the intracellular accumulation of glucose metabolites in the heart reactivates the fetal gene program, which
can be prevented by the impairment of insulin-mediated glucose uptake. Specific Aim 2 will define the effect
of MIR on energy metabolism and contractile function of the heart subjected to chronic pressure overload.
Specifically, it will test the hypothesis that MIR increases glucose oxidation while limiting glucose uptake, and
delays the transition toward failure of the stressed heart. Specific Aim 3 will seek to identify the molecular
mechanism controlling substrate selection in the stressed heart. It will test the hypothesis that the uncoupling
protein 3 (UCP3) decreases efficiency of the heart subjected to a high workload by inhibiting glucose oxidation.
These aims will be addressed by combining my experience in molecular biology to the techniques available in
the mentor’s laboratory, and will set the path to future investigations aiming to define the links between insulin
signaling and the expression of UCP3 in the heart. Collectively, the proposed work seeks to demonstrate that
MIR is more a physiological response for the stressed heart in diabetes, rather than a primary cause for heart
failure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Basis of Postischemic Maladaptation in the Insulin Resistant Heart
-
批准号:9899301
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2018
-
负责人:Romain Harmancey
-
依托单位:
Molecular Basis of Postischemic Maladaptation in the Insulin Resistant Heart
-
批准号:10153852
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2018
-
负责人:Romain Harmancey
-
依托单位:
Molecular Basis of Postischemic Maladaptation in the Insulin Resistant Heart
-
批准号:10595939
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2018
-
负责人:Romain Harmancey
-
依托单位:
Unexpected Consequences of Insulin Resistance for the Heart
-
批准号:8985384
-
项目类别:
-
资助金额:$24.07万
-
财政年份:2015
-
负责人:Romain Harmancey
-
依托单位:
Unexpected Consequences of Insulin Resistance for the Heart
-
批准号:8509455
-
项目类别:
-
资助金额:$8.87万
-
财政年份:2013
-
负责人:Romain Harmancey
-
依托单位:
Unexpected Consequences of Insulin Resistance for the Heart
-
批准号:8704769
-
项目类别:
-
资助金额:$8.87万
-
财政年份:2013
-
负责人:Romain Harmancey
-
依托单位:
海外基金